VTRVentas
Is the price fair?
At the top of its own P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Expensive vs its own history: P/E 163.8 vs a 38.3 median over 29 quarters (+328% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What VTR's price assumes
Ventas trades at 164× earnings against 38.9× for the median REIT - Healthcare Facilities name, more expensive than its own group.
Trailing P/E · REIT - Healthcare Facilities median 38.9 · 4.21× the median: the market pays up for this one
- Price / sales
- 6.86
Price / sales · as of 2026-Q2
- Price / book
- 3.02
Price / book · as of 2026-Q2
- EV / sales
- 8.85
EV / sales
Details›
- Price / bookas of 2026-Q2
- 3.02
- EV / EBITas of 2026-Q2
- 271
- EV / salesas of 2026-Q2
- 8.85
- Real Estate median P/E130 names
- 26.0
- REIT - Healthcare Facilities median P/E11 names
- 38.9
- Market capitalisation512.9 million shares, counted Jul 28, 2026
- $44.5B
| Method | Per share |
|---|---|
| What its own history would imply | not meaningful, 164× today against a 38.3× median |
| 52-week range | $68.91 – $100.56 |
| Today | $86.80 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
REIT, Healthcare Facilities
The closest names by size in the same industry